Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated with Mayzent (siponimod): An OTIS Observational Pregnancy Surveillance Study

21/06/2021
18/07/2024
EU PAS number:
EUPAS41495
Study
Ongoing
Documents
Study protocol
Initial protocol
English (1.05 MB - PDF) View document
Updated protocol
English (940.31 KB - PDF) View document
Study results
No information provided.
Study report
No information provided.
ENCePP Seal
No information provided.